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Strengths and limitations of this study
 ► This cohort study included 10.1 million patients with 
69.3 million patient- years of follow- up at 706 UK 
family practices from 2002 to 2017.
 ► The study included all antibiotic prescriptions and 
classified them according to the medical conditions 
recorded on the same date.
 ► The study relied on medical conditions recorded by 
healthcare professionals in primary care.
 ► Missing and misclassified information might result 
in bias, which might generally be towards a null 
finding.
 ► The study aimed to evaluate associations at the 
general practice level and the results do not exclude 
the possibility of association at the individual patient 
level.
AbStrACt
Objective This study evaluated whether serious 
bacterial infections are more frequent at family practices 
with lower antibiotic prescribing rates.
Design Cohort study.
Setting 706 UK family practices in the Clinical Practice 
Research Datalink from 2002 to 2017.
Participants 10.1 million registered patients with 
69.3 million patient- years’ follow- up.
Exposures All antibiotic prescriptions, subgroups of 
acute and repeat antibiotic prescriptions, and proportion 
of antibiotic prescriptions associated with specific- coded 
indications.
Main outcome measures First episodes of serious 
bacterial infections. Poisson models were fitted adjusting 
for age group, gender, comorbidity, deprivation, region 
and calendar year, with random intercepts representing 
family practice- specific estimates.
results The age- standardised antibiotic prescribing 
rate per 1000 patient- years increased from 2002 (male 
423; female 621) to 2012 (male 530; female 842) 
before declining to 2017 (male 449; female 753). The 
median family practice had an antibiotic prescribing 
rate of 648 per 1000 patient- years with 95% range for 
different practices of 430–1038 antibiotic prescriptions 
per 1000 patient- years. Specific coded indications 
were recorded for 58% of antibiotic prescriptions at 
the median family practice, the 95% range at different 
family practices was from 10% to 75%. There were 
139 759 first episodes of serious bacterial infection. 
After adjusting for covariates and the proportion of 
coded consultations, there was no evidence that serious 
bacterial infections were lower at family practices with 
higher total antibiotic prescribing. The adjusted rate 
ratio for 20% higher total antibiotic prescribing was 
1.03, (95% CI 1.00 to 1.06, p=0.074).
Conclusions We did not find population- level 
evidence that family practices with lower total 
antibiotic prescribing might have more frequent 
occurrence of serious bacterial infections overall. 
Improving the recording of infection episodes has 
potential to inform better antimicrobial stewardship in 
primary care.
IntrODuCtIOn
Antimicrobial resistance is a growing concern 
for health systems. The G20 health minis-
ters noted that ‘drug- resistant (organisms) 
are to blame for 700 000 deaths worldwide 
each year, and this figure is predicted to rise 
to 10 million by 2050 if urgent action is not 
taken.’1 There are now intense efforts to 
reduce unnecessary use of antibiotics, espe-
cially in primary care where 80% of antibi-
otics are prescribed. These antimicrobial 
stewardship programmes have met with some 
success. In England, the total quantity of anti-
biotics prescribed in primary care declined 
by 13.2% in the 5 years between 2013 and 
2017.2 3 Bacterial infections are still of public 
health importance with 1.7 million cases 
of sepsis and 270 000 deaths per year in the 
USA.4 Strategies to reduce inappropriate use 
of antibiotics must ensure that antibiotics can 
be used when they are needed.5 6
It is possible that reducing antibiotic 
prescribing might be associated with greater 
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risk of serious bacterial infections. Previous research 
investigated infection risk and antibiotic prescribing for 
respiratory illnesses.3 7 In a cohort study, Petersen et al8 
found that antibiotic treatment reduced risks of mastoid-
itis after otitis media, peritonsillar abscess after sore 
throat and pneumonia after respiratory infection. An 
analysis of electronic health records9 found that family 
practices that prescribed antibiotic more frequently to 
patients with self- limiting respiratory illnesses might 
have lower risk of pneumonia and peritonsillar abscess 
but there were no associations with risk of mastoiditis, 
empyema, meningitis, intracranial abscess or Lemierre’s 
syndrome. A cluster- randomised trial of an antimicrobial 
stewardship intervention for respiratory prescribing,10 as 
well as an interrupted time series analysis found no clear 
evidence that antimicrobial stewardship policies might be 
associated with increased bacterial infections overall.11 
However, Gharbi et al12 found that apparent non- use of 
antibiotics for urinary infections might be associated with 
higher risk of sepsis.
It is important to extend these investigations to include 
antibiotic prescribing for all indications because the 
reasons for antibiotic prescribing may not always be well 
documented, with up to half of antibiotic prescriptions in 
UK primary care not associated with any record of specific 
diagnostic medical codes.3 7 When analyses are restricted 
to antibiotic prescriptions for clearly recorded indica-
tions, the true extent of antibiotic prescribing may be 
underestimated. It is also important to assess repeat anti-
biotic prescriptions which may be given for prevention of 
recurrent infections or treatment of serious or chronic 
infections.3 The present study aimed to test the hypoth-
esis that greater use of antibiotics for all indications might 
be associated with lower risk of serious bacterial infection. 
We also investigated whether patterns of medical coding 
were associated with the apparent occurrence of serious 
bacterial infection.
MEthODS
Data source
We carried out a population- based cohort study in the UK 
Clinical Practice Research Datalink (CPRD) employing 
data for 2002–2017. The CPRD is one of the world’s largest 
databases of primary care electronic health records, with 
participation of about 7% of UK family practices and 
with ongoing collection of anonymised data from 1990.13 
The high quality of CPRD data has been confirmed in 
many studies.14 In order to estimate family practice- level 
prescribing metrics, we analysed a sample of CPRD data. 
This was because it was not feasible to analyse all anti-
biotic prescription for the whole of CPRD because the 
resulting dataset would have been too large for analysis. 
However, we ascertained serious bacterial infection events 
from the entire population of CPRD because these are 
generally rare events. The protocol for the study has been 
published.
Selection of sample for antibiotic prescribing analysis
In order to analyse antibiotic prescribing, a sample was 
drawn from the CPRD denominator file for the October 
2018 release of CPRD. A random sample of registered 
patients was drawn, stratifying by year between 2002 and 
2017 and by family practice. In each year of study, a sample 
of 10 participants was taken for each gender and age group 
using 5- year age groups up to a maximum of 104 years. Each 
sampled participant contributed data in multiple years of 
follow- up. There was a total sample of 671 830 individual 
participants, registered at a total of 706 family practices, 
who contributed person time between 2002 and 2017. The 
sampling design enabled estimation of all age- specific rates 
with similar precision, while age- standardisation provided 
weightings across age groups.
Main measures for antibiotic prescribing
For each participant in the antibiotic prescribing sample, 
we calculated the person- time at risk between the start and 
end of the patient’s record. Person time was grouped by 
gender, age group and comorbidity. Age groups were from 
0 to 4, 5 to 9 and 10 to 14 and then 10 years age groups up 
to 85 years and over. Comorbidity was evaluated as either 
present or absent in each person- year using the ‘seasonal 
influenza at risk codes’ which are used to identify individuals 
at higher risk of infection who may benefit from influenza 
vaccination,15 as reported previously.10 Seasonal influenza 
at risk Read codes include medical diagnostic codes for 
overweight and obesity, coronary heart disease, chronic 
kidney disease, chronic liver disease, chronic neurological 
disease, chronic respiratory disease, diabetes mellitus and 
disorders of the immune system and drug product codes for 
asthma therapy, corticosteroid drugs and immunosuppres-
sive drugs. Conditions were coded as present if they were 
ever diagnosed up to the end of the study year. Collectively, 
these provide a summary measure of potential susceptibility 
to infection complications.
Antibiotic prescriptions were evaluated using product 
codes for antibiotics listed in section 5.1 of the British 
National Formulary, excluding methenamine and drugs 
for tuberculosis, and leprosy. Different antibiotic classes 
and antibiotic doses were not considered further in this 
analysis. Multiple antibiotic prescription records on the 
same day were considered as a single antibiotic prescrip-
tion. Medical codes recorded on the same date as the 
antibiotic prescription were used to classify the indication 
for prescription using categories of ‘respiratory’, ‘genito-
urinary’, ‘skin’ and ‘other specific’ indications. All other 
codes were classified as ‘non- specific’ codes.3 A prescrip-
tions was classified as ‘acute’ if it was the first prescrip-
tion in a sequence or ‘repeat’ prescription otherwise, as 
reported previously.3 Antibiotic prescriptions that were 
not associated with medical codes and were not repeat 
prescriptions were classified as ‘no codes recorded’.
Serious bacterial infections
Incident cases of serious bacterial infection were evalu-
ated in the January 2019 release of CPRD for the years 
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Table 1 Groups of serious bacterial infections including numbers of medical codes and five most frequently recorded 
conditions
Group
No of 
codes
No of first 
events Five most frequent conditions (no of first events 2002–2017)
CNS infection 30 576 Epidural abscess (117), cerebral abscess (112), brain abscess (79), intraspinal 
abscess (49), drainage of abscess of subdural space (44)
CVS infection 24 1697 Acute and subacute endocarditis (594), bacterial endocarditis (276), subacute 
bacterial endocarditis (270), acute endocarditis NOS (166), acute bacterial 
endocarditis (114)
Kidney infection 22 30 827 Acute pyelonephritis (19 284), pyelonephritis unspecified (7115), infections of 
kidney (1670), acute pyelitis (1008), pyelitis unspecified (745)
Lung abscess/
empyema
24 2932 Empyema (2314), abscess of lung (149), abscess of lung and mediastinum (139), 
thorax abscess NOS (68), pleural empyema (56)
Mastoiditis 10 1970 Mastoiditis and related conditions (1293), mastoiditis NOS (487), acute 
mastoiditis (146), acute mastoiditis NOS (31), abscess of mastoid27
Osteomyelitis 65 4921 Acute osteomyelitis (3297), unspecified osteomyelitis (678), unspecified 
osteomyelitis of unspecified site (284), osteomyelitis jaw (78), unspecified 
osteomyelitis NOS (75)
Peritonsillar 
abscess
6 11 338 Quinsy (8611), peritonsillar abscess—quinsy (1748), O/E quinsy present (654), 
drainage of peritonsillar abscess (232), drainage of quinsy (226)
Resistant 
infections and 
Clostridium 
difficile
31 42 185 C. difficile toxin detection (20 175), methicillin- resistant Staphylococcus aureus 
positive (9914), C. difficile infection (6397), methicillin- resistant S. aureus (4303), 
methicillin- resistant S. aureus carrier (1017)
Sepsis 100 39 059 Sepsis (23 149), septicaemia (6204), urosepsis (4646), biliary sepsis (1233), C. 
infection (576)
Septic arthritis 41 4254 Septic arthritis (3649), pyogenic arthritis (184), arthropathy associated with 
infections (172), knee pyogenic arthritis (52), staphylococcal arthritis and 
polyarthritis (39)
Figures are frequencies.
CNS, central nervous system; CVS, cardiovascular system; NOS, not otherwise specified.
2002–2017 with the CPRD denominator providing the 
person time at risk. CPRD records include details of 
consultations by general practice staff, as well as coded 
records of referrals to hospital or discharge letters from 
hospitals. The mean duration of follow- up was 6.9 years. 
Serious bacterial infections were selected for study from 
review of the International Classification of Diseases 10th 
revision,16 the Read code classification17 and through 
discussion with the research team. The final list of condi-
tions is summarised in table 1 and included: bacterial 
infections of the central nervous system; bacterial infec-
tions of the cardiovascular system; kidney infections; 
lung abscess and empyema; mastoiditis; osteomyelitis; 
peritonsillar abscess; resistant infections and Clostridium 
difficile; sepsis and septic arthritis. Incident events were 
first records for each type of serious bacterial infection 
in a patient more than 12 months after the start of the 
patient record. However, a single patient might have first 
episodes of more than one type of bacterial infection. 
Possible recurrent events in the same patient were not 
evaluated further because, in electronic health records, it 
may not be possible to distinguish new occurrences from 
reference to ongoing or previous problems.
Statistical analysis
The analysis was in two stages. First, we estimated family 
practice- specific estimates for antibiotic prescribing; 
second, we evaluated whether these estimates were associ-
ated with the risk of serious bacterial infection. In the first 
stage of the analysis, we analysed antibiotic prescribing in 
primary care between 2002 and 2017 (online supplemen-
tary table 1: model 1). A hierarchical Poisson model was 
fitted using the ‘hglm’ package in the R programme,18 with 
counts of antibiotic prescriptions as the outcome and the 
log of person time as the offset. Estimates were adjusted 
for the fixed effects of gender, age group, fifth of depriva-
tion at family practice level, comorbidity and region in the 
UK. Calendar year was included as a continuous predictor 
together with quadratic and cubic terms to allow for non- 
linear trends. Random intercepts were estimated for 
each family practice and each estimate represented the 
adjusted log relative rate for antibiotic prescribing at that 
practice compared with the overall mean. The propor-
tion of antibiotic prescriptions that were associated with 
specific medical codes was analysed in a similar framework 
with coded prescriptions as the outcome and the log of 
antibiotic prescriptions as the offset.
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Figure 1 Age- standardised and sex- standardised antibiotic 
prescribing rates per 1000 patient- years for coded and not 
coded indications from 2002 to 2017. AB, antibiotic; GUTI, 
genito- urinary tract infection; RTI, respiratory tract infection.
In the second stage of analysis, serious bacterial infec-
tions were analysed as the outcome (online supplemen-
tary table 1: model 2). The antibiotic prescribing level for 
each family practice was included as a predictor using the 
family practice- specific estimates from model 1. These 
estimates initially had a mean of 0 and SD of 0.19, consis-
tent with an adjusted relative rate of antibiotic prescribing 
of 1.21 for a family practice with prescribing 1 SD above 
the mean. Estimates were, therefore, standardised to give 
the change in serious bacterial infection for a 20% rela-
tive increase in antibiotic prescribing rate at a practice, 
because this represents a change of approximately 1 SD. 
A 20% change generally represents a substantial change 
in antibiotic prescribing. We also estimated the change 
in serious bacterial infection for a 20% relative increase 
in proportion of antibiotic prescriptions with specific 
medical codes recorded at a family practice. Models were 
adjusted for age group, gender, region, deprivation fifth, 
calendar year (including quadratic and cubic terms for 
the latter), with log of person- time as offset. The results 
were visualised using forest plots.19
Patient and public involvement
The protocol and results of the study were discussed at 
meetings with patients. Patients commented on the recent 
declining trend in antibiotic prescribing. They noted 
that avoiding antibiotics requires trade- offs between 
the limited benefits from antibiotic treatment, the side 
effects of antibiotic use,and the potential from longer- 
term problems from the increase in antimicrobial resis-
tance. Patients considered that risks of serious bacterial 
infections were generally low at the present time. There 
is a need to communicate these results to patients and 
prescribers so that both groups can be aware of the wider 
contextual issue of antimicrobial resistance to inform 
antibiotic prescribing decisions.
rESultS
There were 706 family practices included in the analysis, 
with 10.1 million registered patients and 69.3 million 
patient- years of follow- up. In the subsample analysed for 
antibiotic prescribing, there were 706 family practices 
with 6 541 195 person- years of follow- up (online supple-
mentary figure 1 and online supplementary table 2). 
There were a total of 4 371 715 antibiotic prescriptions 
between 2002 and 2017. This included 2 368 551 (54%) 
with coded indications including 1 531 645 (35%) asso-
ciated with respiratory infections, 369 389 (8%) with 
genitourinary infections, 414 680 (10%) with skin infec-
tions and 52 837 (1%) with other specific indications. 
There were 2 003 164 (46%) of antibiotic prescriptions 
without specific coded indications consisting of 479 421 
(11%) repeat prescriptions, 1 154 789 (26%) with non- 
specific medical codes recorded and 368 954 (8%) with 
no medical codes recorded.
Online supplementary figure 2 shows changes over 
time in age- standardised antibiotic prescribing rates per 
1000 patient- years for coded and not coded indications. 
During the initial period of the study from 2002 to 2012, 
the age- standardised total antibiotic prescribing rate per 
1000 patient- years increased from 2002 (male 423; female 
621) to 2012 (male 530; female 842) before declining to 
2017 (male 449; female 753). The recent decrease in total 
antibiotic prescribing was accompanied by a decline in 
antibiotic prescribing for coded indications, but antibiotic 
prescriptions that were not associated with specific coded 
indications continued to increase. There was evidence of 
a decline in antibiotic prescribing for respiratory illness 
from 2008 onwards (figure 1) and after 2012 there was 
evidence of decreasing prescribing for genitourinary 
and skin infections, as well as other specific indications. 
Throughout the period from 2002 to 2017, antibiotic 
prescriptions associated with non- specific codes increased 
as did repeat prescriptions. Antibiotic prescriptions that 
were not associated with medical codes declined initially 
but then remained constant (figure 1).
Table 2 summarises variation in antibiotic prescribing 
metrics between family practices in the sample. The 95% 
range for family practice- specific antibiotic prescribing 
rates was from 430 to 1038 antibiotic prescriptions per 
1000 person- years, with a median of 648 antibiotic 
prescriptions per 1000 patient- years. The 95% range for 
the proportion of repeat prescriptions was from 3% to 
24%. The 95% range for the proportion of antibiotic 
prescriptions with specific coded indications recorded 
ranged from 10% to 75%.
There were 139 759 first episodes of serious bacterial 
infections (online supplementary table 3). Figure 2 shows 
trends in the age- standardised incidence of serious bacterial 
infections from 2002 to 2017. The total incidence of serious 
bacterial infections increased during the period. This 
increase was largely accounted for by increases in sepsis, anti-
biotic resistant and C. difficile infections, kidney infections 
and osteomyelitis. The remaining conditions showed either 
stable incidence or slight declines. Online supplementary 
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Table 2 Variation in antibiotic prescribing between family practices
Measure
Centiles of family practices
2.5th 25th Median 75th 97.5th
AB prescribing rate per 1000 patient- years 430 563 648 748 1038
Acute prescriptions (% of all antibiotic prescriptions) 76 86 90 93 97
Repeat prescriptions (% of all antibiotic prescriptions) 3 7 10 14 24
Coded indication (% of all antibiotic prescriptions) 10 48 58 65 75
Respiratory (% of all antibiotic prescriptions) 6 31 36 42 52
Genitourinary (% of all antibiotic prescriptions) 1 7 8 11 16
Skin (% of all antibiotic prescriptions) 2 8 10 12 16
Other specific (% of all antibiotic prescriptions) 0 1 1 2 3
Non- coded indications (% of all antibiotic prescriptions) 24 35 42 51 90
No codes recorded (% of all antibiotic prescriptions) 1 3 6 11 28
Non- specific codes recorded (% of all antibiotic prescriptions) 12 19 24 29 59
Column per cents are not expected to sum to 100 as different family practices may be represented for the same centile in different rows.
Figures represent the centiles of the distribution of family practice- specific values.
AB, antibiotic.
Figure 2 Age- standardised rates of serious bacterial infections per 1000 patient- years from 2002 to 2017. Red lines, female; 
blue lines, male; shaded areas, 95% CIs. CNS, central nervous system; CVS, cardiovascular system.
table 4 presents age- standardised and sex- standardised 
incidence rates per 1000 patient- years for serious bacterial 
infections for the highest and lowest fourths of antibiotic 
prescribing. There was no evidence that serious bacte-
rial infections might be more frequent at family practices 
in the lowest fourth of antibiotic prescribing. In general, 
age- standardised and sex- standardised incidence rates 
tended to be highest at family practices that were higher 
prescribers of antibiotics. Online supplementary table 4 
also compares the incidence of serious bacterial infection 
for the lowest and highest fourths of medical coding. In 
the lowest quartile of practices a median of 38% antibiotic 
prescriptions were coded, compared with 70% for prac-
tices in the highest quartile. Family practices in the highest 
fourth of medical coding had an incidence of serious bacte-
rial infection of 2.39 per 1000 patient- years (95% CI 2.37 to 
2.42) compared with 1.94 (1.91 to 1.96) in the lowest fourth 
of medical coding.
Figure 3 presents a forest plot for the association of each 
serious bacterial infection with 20% higher total antibiotic 
prescribing at a family practice. The combined estimate 
revealed that there was no evidence that higher total anti-
biotic prescribing was associated with lower incidence of 
serious bacterial infections (adjusted rate ratio (RR) 1.03, 
95% CI 1.00 to 1.06, p=0.074). When the 10 classes of 
serious bacterial infection were considered individually, 
there was no evidence that higher antibiotic prescribing 
might be associated with a lower incidence of infections. 
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Figure 3 Forest plot showing the adjusted rate ratio for 
each type of serious bacterial infection for 20% higher 
total antibiotic prescribing (red) or 20% higher proportion 
of antibiotic prescriptions with specific coded indications 
recorded (grey). Estimates were adjusted for each variable 
shown and gender, age group, comorbidity, deprivation fifth, 
region and year (including quadratic and cubic terms). CNS, 
central nervous system; CVS, cardiovascular system; RR, 
rate ratio; LL, lower limit 95% confidence interval; UL, upper 
limit 95% confidence interval.
However, there was weak evidence of that lung abscess and 
empyema (RR 0.94, 0.88 to 1.00, p=0.038) might be lower 
at higher prescribing family practices. There was strong 
evidence that the recorded incidence of serious bacterial 
infections was associated with the coding of specific indica-
tions for a antibiotic prescriptions (adjusted RR for a 20% 
increase in coding proportion 1.24, 1.18 to 1.29, p<0.001). 
This association held for each of the 10 classes of serious 
bacterial infections considered individually.
We conducted a sensitivity analysis by excluding repeat 
prescriptions that might not have been for acute infection 
episodes. There was no evidence that higher acute (non- 
repeat) antibiotic prescribing was associated with serious 
bacterial infections overall (RR 1.02, 0.99 to 1.05, p=0.227) 
(online supplementary figure 3). There was evidence that 
higher acute antibiotic prescribing might be associated with 
lower incidence of lung abscess and empyema and septic 
arthritis. Osteomyelitis and peritonsillar abscess were not 
judged to be associated with acute antibiotic prescribing 
after controlling the false discovery rate. There was weak 
evidence that higher repeat antibiotic prescribing might be 
associated with higher incidence of serious bacterial infec-
tions overall (RR 1.01, 1.00 to 1.02, p=0.054) with evidence 
of this association for kidney infections, osteomyelitis, peri-
tonsillar abscess and septic arthritis considered separately.
DISCuSSIOn
Principal findings
This study found that antibiotic prescribing increased 
from 2002 to 2012 but declined subsequently with changes 
over time being of larger magnitude for women than 
men. The incidence of serious bacterial infections in men 
and women rose steadily between 2002 and 2017, partic-
ularly for sepsis (men and women), osteomyelitis (mainly 
in men) and kidney infections (mainly in women). The 
research aimed to test the hypothesis that family practices 
with lower utilisation of antibiotics might have greater 
risk of serious bacterial infections. We evaluated the inci-
dence of serious bacterial infections including 10 groups 
of infections that affect different systems of the body as 
well as sepsis (including septicaemia). We did not find 
evidence that family practices that prescribe antibiotics 
less frequently might have a higher incidence of serious 
bacterial infections. We found evidence that each type of 
serious bacterial infection was recorded more frequently 
at family practices that record diagnostic codes for a 
high proportion of antibiotic prescriptions suggesting 
that variation in the incidence of serious bacterial infec-
tion among family practices may be partly an artefact 
of data recording. Measures are needed to improve the 
recording of infection episodes in primary care both 
when antibiotics are prescribed and when they are not. 
Repeat prescriptions account for a significant proportion 
of uncoded prescriptions3 and repeat prescriptions might 
be indicated for prolonged or serious infections. Certain 
conditions may be associated with a higher rate of repeat 
antibiotic prescribing if there is initial treatment failure. 
For example, surgical intervention may eventually be 
required for treatment empyema, osteomyelitis or infec-
tive endocarditis. We conducted analyses after excluding 
repeat prescriptions and these analyses raised the possi-
bility that family practices with lower acute (non- repeat) 
antibiotic prescribing might have higher incidence of 
lung abscess and empyema and septic arthritis. However, 
these analyses were not preplanned, should be considered 
as hypothesis generating and requiring confirmation in 
future studies. The incidence of these two conditions is 
less than one per 10 000 patients per year, and a relative 
rate of 0.9 for a 20% increase in prescribing implies that 
at most one additional case might arise every 10 years 
from a 20% reduction in prescribing at a family practice 
with 10 000 registered patients.
Strengths and weaknesses of the study
The study drew on data for a large population comprising 
data for about 7% of the UK general population. In view 
of sample size constraints, antibiotic utilisation was esti-
mated through analysis of data for a sample of patients, 
using hierarchical (multilevel) regression models to 
obtain family practice- specific antibiotic prescribing esti-
mates. This contrasts with our previous study in which age- 
standardised and sex- standardised rates were calculated 
from the data for each practice.9 Use of a regression model-
ling approach enabled us to make optimal use of the data, 
as well as adjusting for covariates that are associated with 
variations in antibiotic prescribing20 including comorbidity, 
deprivation, region and calendar year, in addition to age 
and sex.21 Consistent with previous studies,3 7 we observed 
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that nearly half of antibiotic prescriptions were not asso-
ciated with specific coded indications. This suggests that 
total antibiotic prescribing is the most appropriate expo-
sure measure for consideration, because indication- specific 
antibiotic prescribing may be associated with considerable 
misclassification. Serious bacterial infections were identi-
fied from medical diagnostic codes recorded into primary 
care electronic health records, which include general 
practice records of consultations, hospital referrals and 
discharges. Many studies have shown that these records 
have a high predictive value for a range of diagnoses,14 but 
relying on a single data source can lead to underestimation 
of the total number of events.22 CPRD records are linked 
to hospital episode statistics (HES) but only for a subset of 
general practices in England, leading to a reduced sample 
size. Further research incorporating HES data are now 
underway and will be reported separately. There may be 
changes over time in the use of diagnostic categories, which 
might in part account for increasing diagnoses of ‘sepsis’. 
A study of US hospitals’ data found that there was a 70.6% 
increase in sepsis between 2003 and 2012, without any 
corresponding increase in positive blood cultures.23 There 
was also an apparent increase in resistant infections but 
this might also be due in part to data recording changes 
and growing awareness of the problem of antimicrobial 
resistance, as well as true increases in resistant infections. 
An interrupted time series analysis11 offers an alterna-
tive approach to analysis but this might be susceptible to 
changes over time in unmeasured confounders such as 
code selection. The results of our study draw attention to 
the problem of poor coding quality in the context of infec-
tion management in primary care. Evidence from other 
studies suggests that missing values are typically missing 
not at random and the act of data recording may intro-
duce a form of confounding by indication that may bias 
results.24 In order to allow for this, we explicitly evaluated 
the extent to which differences in data recording between 
practices might account for variations in the incidence of 
serious bacterial infections. It is likely that misclassification 
of exposure and outcome variables, from incomplete data 
recording, might lead to underestimation of associations, 
though the direction of bias cannot always be anticipated.25 
We adjusted for a summary measure of comorbidity. Our 
analyses do not exclude the possibility that there may be 
vulnerable subgroups of patients, such as those with immu-
nosuppression, who may be at increased risk if antibiotics 
are withheld.
Comparison with other studies
The trends in total antibiotic utilisation reported here 
are consistent with national trends based on aggregate 
data.2 Neilly et al26 found that increasing prescription 
volumes in the period up to 2013 could be accounted 
for by increasing dose and duration of prescriptions but 
we found evidence of increased antibiotic prescribing 
based on numbers of prescriptions alone. Consistent 
with our findings, Balinskaite et al11 reported increasing 
rates of infection in English primary care and hospital 
admissions data from 2010 to 2017. Their time series anal-
ysis suggested that antimicrobial stewardship intervention 
in 2015 had no impact on bacterial infections overall 
but there was some evidence for increasing hospital 
admissions for quinsy, decreasing hospital admissions 
for pyelonephritis and decreasing general practitioner 
consultation rates for empyema. In a previous study, we 
found that peritonsillar abscess and pneumonia might be 
more frequent when family practices prescribe antibiotics 
less frequently for respiratory tract infections.9 We did 
not include pneumonia in this study because we found 
that syndromes of ‘chest infection’ and ‘pneumonia‘ may 
be difficult to distinguish in primary care records with 
evidence of code shifting between the two categories.27 In 
the present study, the incidence of peritonsillar abscess 
was not associated with total antibiotic prescribing. 
Randomised trials suggest that antibiotics protect against 
peritonsillar abscess28 so it is plausible that this condition 
might be associated with respiratory antibiotic prescribing 
but not total antibiotic prescribing.
MAIn COnCluSIOnS
Family practices that reduce the amount of antibiotics 
prescribed do not risk any increase in serious bacterial 
infections overall. This finding does not exclude the 
possibility that serious bacterial infection may be asso-
ciated with antibiotic prescribing patterns at individual 
patient level. Consequently, reducing antibiotic utilisa-
tion in primary care will require a detailed understanding 
of when antibiotics prescriptions are required and when 
they are not and increasing the quality of data recording 
with respect to antibiotic use should be a high priority. 
This study focused on population- level associations at the 
level of family practice. Future research should evaluate 
the associations at the level of the individual patient and 
the individual family practice consultation. This might 
provide primary care professionals and patients with 
objective evidence concerning levels risk that can inform 
decisions to prescribe or not prescribe antibiotics.
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